Subscribe to Newsletter

Content by Stephanie Vine:

Business & Regulation Standards & Regulation

FDA Warning Letters: September 2023 Edition

| Stephanie Vine | 4 min read

A look at cGMP deviations in recent warning letters, including manufacturing conducted in corridors and equipment uncleaned for 14 years.

Discovery & Development Drug Discovery

Llamas Versus Dengue

| Stephanie Vine | 3 min read

Why one company is focusing on camelid-derived antibodies to tackle dengue.

Manufacture Technology and Equipment

Nominate the Best Drug Development and Manufacturing Technologies

| Stephanie Vine

Nominations are open now – but only until October 10.

Manufacture Bioprocessing - Upstream & Downstream

The Future of Biopharma Analytics

| Stephanie Vine | 6 min read

What lies ahead for biopharma manufacturers when it comes to downstream analytical tech?

Business & Regulation Business Practice

Pfizer Fallout

| Stephanie Vine | 3 min read

The pharma giant’s COVID-19 vaccine saved millions of lives, but the company is quickly falling from grace.

Business & Regulation Profession

Celebrating People with Power

| Stephanie Vine

Who are the most influential and inspirational people in drug development and manufacturing? Nominations for the Power List 2024 are now open!

Manufacture Small Molecules

The Contaminated Childrens’ Cough Syrup Scandal

| Stephanie Vine | 4 min read

I explore recent cases of pediatric cough medicines contaminated with diethylene glycol.

Business & Regulation Profession

Leadership: Keeping the Focus on Innovation

| Stephanie Vine | 4 min read

Life sciences is one of the most innovative industries in the world. What are the leadership skills required?

Business & Regulation Standards & Regulation

Why Are Some Medicines Linked to Suicide?

| Stephanie Vine | 3 min read

The EMA is reviewing whether certain Novo Nordisk drugs are linked to suicidal thoughts

Discovery & Development Drug Discovery

The PEPITEM Pathway – and the Path to New Obesity Treatments

| Stephanie Vine | 6 min read

The world needs new medicines to treat obesity-related conditions. Here’s what researchers at the UK’s University of Birmingham are doing about it.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register